WASHINGTON, Sept 30 (Reuters) – GlaxoSmithKline will
pay $20 million to settle civil charges that it masked improper
bribes to foreign officials in China on its books by disguising
them as legitimate…
The post GlaxoSmithKline to pay $20 mln to settle foreign bribery related charges appeared first on NASDAQ.